share_log

Recap: Larimar Therapeutics Q4 Earnings

Recap: Larimar Therapeutics Q4 Earnings

回顧:Larimar Therapeutics第四季度收益
Benzinga ·  03/14 17:15

Larimar Therapeutics (NASDAQ:LRMR) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:05 PM.

Larimar Therapeutics(納斯達克股票代碼:LRMR)於2024年3月14日星期四下午4點05分公佈了其第四季度業績。

Here's what investors need to know about the announcement.

以下是投資者需要了解的有關該公告的信息。

Earnings

收益

Larimar Therapeutics missed estimated earnings by -20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.

Larimar Therapeutics報告的每股收益爲-0.3美元,未達到預期的-20.0%,而預期的收益爲-0.25美元。

Revenue was down $0 from the same period last year.

收入比去年同期下降了0美元。

Past Earnings Performance

過去的收益表現

Last quarter the company beat on EPS by $0.01 which was followed by a 14.000000000000002% increase in the share price the next day.

上個季度,該公司的每股收益超過0.01美元,隨後第二天股價上漲了14.0000000000002%。

** Listen to the earnings announcement yourself by clicking here. **

** 點擊此處親自收聽業績公告。**

To track all earnings releases for Larimar Therapeutics visit their earnings calendar here.

要追蹤Larimar Therapeutics發佈的所有業績,請在此處訪問他們的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閱。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論